BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Nektar Therapeutics Reports Financial Results for the Second Quarter of 2019

  Company to Host Conference Call with Analysts to Review Financial Results and Provide Update on the NKTR-214 Program

  August 8, 2019

   · 

  15 min read
• Business

  Taro Provides Results for Quarter Ended June 30, 2019

  Taro Pharmaceutical Industries today provided unaudited financial results for the quarter ended June 30, 2019.

  August 8, 2019

   · 

  8 min read
• Job Trends

  Back to School Is the Time to Get Tested Before Fall Allergy Season Begins

  Millions of Americans will soon be impacted by the rise in ragweed and other allergy triggers

  August 8, 2019

   · 

  3 min read
• Business

  Diplomat signs exclusive practice-based infusion agreement with Allergy Partners

  This innovative agreement forms the nation’s first large-scale physician practice-based infusion program.

  August 8, 2019

   · 

  5 min read
• Organigram Conditionally Approved to Graduate to the TSX

  Conditional approval from the Toronto Stock Exchange to graduate from the TSX Venture Exchange and list its common shares on the TSX under the symbol “OGI.”

  August 8, 2019

   · 

  4 min read
• Bio NC

  IQVIA Announces Repurchase of Common Stock

  IQVIA expects to fund the Repurchase with cash on hand and borrowings from its revolving credit facility.

  August 8, 2019

   · 

  1 min read
• Business

  Puma Biotechnology Reports Second Quarter 2019 Financial Results

  All comparisons are for the second quarter 2019 compared to the second quarter of 2018.

  August 8, 2019

   · 

  14 min read